John Olichney
Neurology · San Diego, CANPI 1689699969
Payments from drug & device makers
Across 46 payments — averaging $30,515 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$921K
- Genentech, Inc.$357K
- Eisai Inc.$125K
- Merck$117
- Genentech USA, Inc.$92
Across 2 payments — averaging $481.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$962
What the payments were for
- Food & beverage$115100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 16 | $920,814 |
| Genentech, Inc. | 21 | $357,343 |
| Eisai Inc. | 6 | $125,333 |
| Merck | 2 | $117 |
| Genentech USA, Inc. | 1 | $92 |
How this compares
$1,403,699 in reported general payments places this provider in the 95th percentile of 1,996 neurology providers in California.
Other neurology in San Diego
- Chamindra LavertySan Diego$2.3M
- Timothy CloughesyLos Angeles$33.1M
- Jack FlorinFullerton$13M
- David KudrowSanta Monica$12.8M
- John Ravitsla Jolla$8.4M
- Perminder BhatiaFresno$8.3M
- Perry ShiehLos Angeles$8.2M
- Benjamin FrishbergCarlsbad$8.2M
- Bruce CreeSan Francisco$8M
- Lawrence RechtPalo Alto$6.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.